Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

Peripheral Arterial Disease: Features

Dr. Anahita Dua
AMP 2022
Gender Disparities in CLI Patients
08/18/2022
Written by Cynthia Laufenberg, MA Presented by Anahita Dua, MD, FACS At Wednesday’s session “The Amputation Epidemic: Impact on Minority & Underserved Populations,” Dr. Anahita Dua of Massachusetts General Hospital/Harvard Medical...
Written by Cynthia Laufenberg, MA Presented by Anahita Dua, MD, FACS At Wednesday’s session “The Amputation Epidemic: Impact on Minority & Underserved Populations,” Dr. Anahita Dua of Massachusetts General Hospital/Harvard Medical...
Written by Cynthia Laufenberg,...
08/18/2022
Vascular Disease Management
Dr. Bryce
AMP 2022
Closing the Gaps in Racial Disparities in CLI Outcomes and Amputation Rates
08/18/2022
Written by Cynthia Laufenberg, MA Presented by Yolanda Bryce, MD, RVPI At the opening session on the first day of AMP 2022, “The Amputation Epidemic: Impact on Minority & Underserved Populations,” Dr. Yolanda Bryce of Memorial Sloan...
Written by Cynthia Laufenberg, MA Presented by Yolanda Bryce, MD, RVPI At the opening session on the first day of AMP 2022, “The Amputation Epidemic: Impact on Minority & Underserved Populations,” Dr. Yolanda Bryce of Memorial Sloan...
Written by Cynthia Laufenberg,...
08/18/2022
Vascular Disease Management
Dr. Beckman
LINC 2022
The Cost of CLTI: How Many Amputations Occur Each Year and What Is the Cost to the Patient and Society?
08/09/2022
At the VIVA@LINC session of "Big Picture Trends in Chronic Limb-Threatening Ischemia," Joshua Beckman, MD, from Boston, Massachusetts, presented the cost implications–in every sense–of amputation.
At the VIVA@LINC session of "Big Picture Trends in Chronic Limb-Threatening Ischemia," Joshua Beckman, MD, from Boston, Massachusetts, presented the cost implications–in every sense–of amputation.
At the VIVA@LINC session of "Big...
08/09/2022
Vascular Disease Management
Dr. Marianne Brodmann
Video
IN.PACT Global Study: 5-Year Diabetic and Gender Subgroup Outcomes
07/31/2022
In this video from iSET 2022, Dr. Brodmann reviews the 5-year diabetic and gender subgroup outcomes from the IN.PACT Global Study.
In this video from iSET 2022, Dr. Brodmann reviews the 5-year diabetic and gender subgroup outcomes from the IN.PACT Global Study.
In this video from iSET 2022,...
07/31/2022
Vascular Disease Management
Complex Pedal Loop Reconstruction
Video AMP 2022
Complex Pedal Loop Reconstruction
07/07/2022
In this complex CLI case, endovascular intervention was performed on a patient with a wound on the left foot. We overcome challenging CTO crossing in the arteries of the pedal loop in order to establish the best flow possible for wound...
In this complex CLI case, endovascular intervention was performed on a patient with a wound on the left foot. We overcome challenging CTO crossing in the arteries of the pedal loop in order to establish the best flow possible for wound...
In this complex CLI case,...
07/07/2022
Vascular Disease Management
Interview and Case Report
Treating Calcified PAD With the New Shockwave M5+ IVL Catheter
07/06/2022
VDM speaks with vascular surgeon Halim Yammine, MD, about treating calcified PAD with the Shockwave M5+ IVL catheter.
VDM speaks with vascular surgeon Halim Yammine, MD, about treating calcified PAD with the Shockwave M5+ IVL catheter.
VDM speaks with vascular surgeon...
07/06/2022
Vascular Disease Management
Strategy
First-Time Data Release/LINC 2022
Treating Common Femoral Artery Steno-occlusive Lesions With an Endovascular Approach Using DA + DCB: 3-year Follow-up in 75 Patients
06/12/2022
Dr. Angelo Cioppa, from Montevergine Clinic in Mercogliano, Italy, shared the results of a study that looked at combining the advantages of open surgery with endovascular surgery.
Dr. Angelo Cioppa, from Montevergine Clinic in Mercogliano, Italy, shared the results of a study that looked at combining the advantages of open surgery with endovascular surgery.
Dr. Angelo Cioppa, from...
06/12/2022
Vascular Disease Management
Outcomes
First-Time Data Release/LINC 2022
Predictors of Drug-Coated Balloon Efficacy in Femoropopliteal Intervention: Insights From a Patient-Level Pooled Analysis
06/11/2022
Prakash Krishnan, MD, from Mount Sinai Health System in New York, shared the results of a study that evaluated the predictors of drug-coated balloon outcomes in a large, rigorous dataset with the use of core labs and CEC adjudication
Prakash Krishnan, MD, from Mount Sinai Health System in New York, shared the results of a study that evaluated the predictors of drug-coated balloon outcomes in a large, rigorous dataset with the use of core labs and CEC adjudication
Prakash Krishnan, MD, from Mount...
06/11/2022
Vascular Disease Management
Editor's Corner
Thirteen Steps to Avoid Radial Artery Access Complications in Peripheral Arterial Interventions
06/11/2022
Dr. Walker discusses 13 steps to avoid complications with peripheral arterial interventions.
Dr. Walker discusses 13 steps to avoid complications with peripheral arterial interventions.
Dr. Walker discusses 13 steps to...
06/11/2022
Vascular Disease Management
Drs. Montero-Baker and Somerset
LINC 2022
Ultrasound-based Calcium Score for the Identification of No-Option CLTI
06/09/2022
Dr. Miguel Montero-Baker and Dr. Jill Somerset introduce a study to correlate and validate a proposed scoring system for early identification of patients at risk for reinterventions.
Dr. Miguel Montero-Baker and Dr. Jill Somerset introduce a study to correlate and validate a proposed scoring system for early identification of patients at risk for reinterventions.
Dr. Miguel Montero-Baker and Dr....
06/09/2022
Vascular Disease Management

Advertisement

Advertisement

Stay in the Know

Vascular Disease Management Newsletter

Advertisement

Advertisement

News

First Aid guidelines
AHA/American Red Cross: Updated First Aid Guidelines Enhance Care for Opioid Overdose, Bleeding, Other Emergencies
11/14/2024
These are the first major comprehensive updates to the first aid guidelines since 2010 and address shifts in how the public manages common and critical first aid emergencies.
These are the first major comprehensive updates to the first aid guidelines since 2010 and address shifts in how the public manages common and critical first aid emergencies.
These are the first major...
11/14/2024
Cath Lab Digest
Late-Breaking Trials
Final Round of Late-Breaking Clinical Trial Results Announced at VIVA24
11/06/2024
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the final round of Late-Breaking Clinical Trials presented at...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the final round of Late-Breaking Clinical Trials presented at...
The VIVA Foundation, a...
11/06/2024
Vascular Disease Management
Late-Breaking Trials
Third Round of Late-Breaking Clinical Trial Results Announced at VIVA24
11/05/2024
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the third of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the third of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a...
11/05/2024
Vascular Disease Management
Late-Breaking Trials
Second Round of Late-Breaking Clinical Trial Results Announced at VIVA24
11/04/2024
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the second of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the second of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a...
11/04/2024
Vascular Disease Management
Late-Breaking Trials
First Round of Late-Breaking Clinical Trial Results Announced at VIVA24
11/04/2024
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the first of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the first of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a...
11/04/2024
Vascular Disease Management
Image-Guided Therapy
Philips Enrolls First Patient in U.S. Clinical Trial for Innovative Integrated Single-Device to Treat Peripheral Artery Disease
11/04/2024
With a unique world-first ability to perform laser atherectomy and laser-based intravascular lithotripsy using a single device, Philips takes a major step forward in the treatment of peripheral artery disease (PAD) Cardiovascular...
With a unique world-first ability to perform laser atherectomy and laser-based intravascular lithotripsy using a single device, Philips takes a major step forward in the treatment of peripheral artery disease (PAD) Cardiovascular...
With a unique world-first...
11/04/2024
Vascular Disease Management
Pulmonary Embolism
Akura Medical Secures FDA Approval for US Pivotal Trial in Pulmonary Embolism
11/04/2024
QUADRA-PE study will evaluate the safety and effectiveness of the Katana™ Thrombectomy System LOS GATOS, Calif., Nov. 4, 2024 /PRNewswire/ -- Akura Medical, a Shifamed portfolio company focused on reshaping the...
QUADRA-PE study will evaluate the safety and effectiveness of the Katana™ Thrombectomy System LOS GATOS, Calif., Nov. 4, 2024 /PRNewswire/ -- Akura Medical, a Shifamed portfolio company focused on reshaping the...
QUADRA-PE study will evaluate...
11/04/2024
Vascular Disease Management
Peripheral Arterial Disease
FDA Grants R3 Vascular IDE Approval for ELITE-BTK Pivotal Trial of its MAGNITUDE® Drug Eluting Next Generation Bioresorbable Scaffold for Below-the-Knee Peripheral Arterial Disease
11/04/2024
MOUNTAIN VIEW, Calif. – November 4, 2024 – R3 Vascular Inc., a medical device company dedicated to developing and providing novel, best-in-class bioresorbable scaffolds for treating peripheral arterial disease (PAD), is pleased to announce...
MOUNTAIN VIEW, Calif. – November 4, 2024 – R3 Vascular Inc., a medical device company dedicated to developing and providing novel, best-in-class bioresorbable scaffolds for treating peripheral arterial disease (PAD), is pleased to announce...
MOUNTAIN VIEW, Calif. – November...
11/04/2024
Vascular Disease Management
Patient Awareness
Baby Boomers Beware: More Americans Than Ever Before Now at Higher Risk for Common Blood Vessel Diseases
10/31/2024
New survey reveals nearly one in three Americans at highest risk for blood vessel diseases and life-threatening complications report low awareness Society for Vascular Surgery launches the Highway to Health campaign to help people maintain...
New survey reveals nearly one in three Americans at highest risk for blood vessel diseases and life-threatening complications report low awareness Society for Vascular Surgery launches the Highway to Health campaign to help people maintain...
New survey reveals nearly one in...
10/31/2024
Vascular Disease Management
DCB
SIRONA Trial @TCT – First Head-to-Head Comparison of Sirolimus Versus Paclitaxel DCBs in the Treatment of PAD: Sirolimus-Coated Balloons Yield Similar Results to Paclitaxel-Coated Balloons in the Femoropopliteal Artery
10/30/2024
Data from the prospective, multicenter, investigator-initiated SIRONA randomized clinical trial demonstrated MagicTouch™️ sirolimus-coated balloons to be noninferior compared to paclitaxel-coated balloons with regards to the primary safety...
Data from the prospective, multicenter, investigator-initiated SIRONA randomized clinical trial demonstrated MagicTouch™️ sirolimus-coated balloons to be noninferior compared to paclitaxel-coated balloons with regards to the primary safety...
Data from the prospective,...
10/30/2024
Cath Lab Digest

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use

Advertisement

Advertisement